Edinburgh Research Explorer

MS-STAT2: A phase 3 randomised, double blind, clinical trial investigating the effectiveness of repurposed simvastatin compared to placebo in secondary progressive multiple sclerosis, in slowing the progression of disability

Project: Research

StatusActive
Effective start/end date1/03/1731/08/23
Total award£78,785.00
Funding organisationOther
Funder project reference539549
Period1/03/1731/08/23